WOBURN, Mass.--(BUSINESS WIRE)--ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality-of-life for sufferers of articular cartilage injuries, today announced that results of a retrospective follow-up analysis of commercial patients that received the BioCart™ Autologous Cartilage System are being presented (poster P239) at the 9th World Congress of the International Cartilage Repair Society (ICRS) in Barcelona.
